l9n/ Connecticut

2019 Regular Session

Senate Bill 48

AN ACT REQUIRING MANUFACTURERS OF BRAND NAME PRESCRIPTION DRUGS TO PROVIDE SAMPLES OF SUCH DRUGS TO MANUFACTURERS OF GENERIC PRESCRIPTION DRUGS.

Did not become law. It stopped in the Senate on May 21, 2019. The 2019 session has ended.

What it does

The synopsis the General Assembly published with the bill.

To promote competition in the prescription drug market by allowing developers of generic drugs and biosimilar products to obtain reference samples.

Sponsors

Who carried the bill in each chamber, and who signed on. Each name leads to the member's page.

In the Senate

1 co-sponsor

Martin M. Looney

Its course

January 15 to May 21, 2019, on one scale. In the top row each mark is a day something happened; taller marks are busier days.

Each committee stop sits inside its chamber.

Every action28 actions on 17 days

In the SenateJan 15 to May 21 · stopped126 days

Public Health CommitteeJan 15 to Jan 18 · moved on3 days

General Law CommitteeJan 18 to Mar 2162 days

Judiciary CommitteeApr 24 to Apr 306 days

Appropriations CommitteeMay 17 to May 214 days

Text

Each version as the General Assembly printed it.

l9n doesn't hold this bill's text yet.

What happened

In l9n's words, one line for each step. Every action as the General Assembly published it is below.

In the Senate Jan 15 – May 21

  1. Jan 15Introduced and sent to Public Health Committee
  2. Jan 18Sent to General Law Committee
  3. Feb 15Heard in General Law Committee
  4. Mar 19Drafted as a bill by General Law Committee
  5. Mar 20Sent to General Law Committee
  6. Mar 21General Law Committee recommended it
  7. Apr 24Sent to Judiciary Committee
  8. Apr 30Judiciary Committee recommended it
  9. May 17Sent to Appropriations Committee
  10. May 21Appropriations Committee recommended it
All 28 actions, as published
  1. Jan 15REF. TO JOINT COMM. ONBoth houses
  2. Jan 18Change of ReferenceBoth houses
  3. Jan 22CHG. REF., SEN. TO COMM. ONSenate
  4. Jan 22CHG. REF., HOUSE TO COMM. ONHouse of Representatives
  5. Jan 31Reserved for Subject Matter Public HearingBoth houses
  6. Feb 15PUBLIC HEARINGBoth houses
  7. Mar 5Vote to DraftBoth houses
  8. Mar 19DRAFTED BY COMMITTEEBoth houses
  9. Mar 20REF. TO JOINT COMM. ONBoth houses
  10. Mar 21Joint FavorableBoth houses
  11. Mar 22FILED WITH LCOBoth houses
  12. Mar 29REFERRED TO OLR, OFABoth houses
  13. Apr 4RPTD. OUT OF LCOBoth houses
  14. Apr 4FAV. RPT., TAB. FOR CAL., SEN.Senate
  15. Apr 4SENATE CALENDAR NUMBERSenate
  16. Apr 4FILE NO.Both houses
  17. Apr 24REF. BY SEN. TO COMM. ONSenate
  18. Apr 30Joint FavorableBoth houses
  19. May 1FILED WITH LCOBoth houses
  20. May 1RPTD. OUT OF LCOBoth houses
  21. May 1NO NEW FILE BY COMM. ONBoth houses
  22. May 1FAV. RPT., TAB. FOR CAL., SEN.Senate
  23. May 17REF. BY SEN. TO COMM. ONSenate
  24. May 21Joint FavorableBoth houses
  25. May 21FILED WITH LCOBoth houses
  26. May 21RPTD. OUT OF LCOBoth houses
  27. May 21NO NEW FILE BY COMM. ONBoth houses
  28. May 21FAV. RPT., TAB. FOR CAL., SEN.Senate